Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti‐Tumor Agent

Glioblastoma (GBM) is a devastating inflammation‐related cancer for which novel therapeutic targets are urgently required. Previous studies of the authors indicate Cytochrome P450 2E1 (CYP2E1) as a novel inflammatory target and develop a specific inhibitor Q11. Here it is demonstrated that CYP2E1 ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Guiming, Fang, Yan, Xu, Haiwei, Wang, Guanzhe, Yang, Rui, Gao, Fei, Wei, Qingda, Gu, Yuhan, Zhang, Cunzhen, Qiu, Jinhuan, Gao, Na, Wen, Qiang, Qiao, Hailing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427391/
https://www.ncbi.nlm.nih.gov/pubmed/37283464
http://dx.doi.org/10.1002/advs.202301096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427391/
https://www.ncbi.nlm.nih.gov/pubmed/37283464
http://dx.doi.org/10.1002/advs.202301096

Ejemplares similares